Clinical Trials Logo

Clinical Trial Summary

Insomnia is a common clinical disease.The serious patients could not sleep all night, often accompanied by headache, dizziness, forgetfulness and so on. All of these increase the mental burden of insomnia patients and seriously affected the normal work and quality of life of patients. Modern medical treatment to treat insomnia is using sedative and hypnotic drugs, mainly benzodiazepine, zopiclone. But long-term use of these drugs can induce the adverse reactions, including resistance, dependence and addiction. Many articles indicate that electroacupuncture can effectively improve insomnia, play the role of sedative and hypnotic effect and avoid many adverse reactions and side effects. Then there are no more objective indicators to affirm that which part of brain takes place the appropriate changes when electroacupuncture induces the sedative effect. So we designed this experiment.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01896063
Study type Interventional
Source Xijing Hospital
Contact
Status Completed
Phase Phase 1
Start date September 2011
Completion date May 2014

See also
  Status Clinical Trial Phase
Recruiting NCT02601092 - Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Mini Gastric Bypass N/A
Not yet recruiting NCT01698853 - Difference Between Central and Peripheral Arterial Blood Oxygen Saturation With Different CPB Strategy N/A
Recruiting NCT02295150 - Prophylaxis of Venous Thromboembolism After Bariatric Surgery Phase 4
Withdrawn NCT02328846 - Transcutaneous-Arterial Carbon Dioxide and Microcirculatory Dysfunction
Active, not recruiting NCT02641301 - Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects Phase 4
Completed NCT01379638 - Best Cardiac Output During Cardiopulmonary Bypass N/A
Completed NCT01450475 - Study of Remote Ischemic Postconditioning Phase 1